Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,000
Closed -$400K 5572
2026
Q1
$400K Buy
+10,000
New +$473K ﹤0.01% 3311
2025
Q3
Sell
-32,200
Closed -$1.55M 5686
2025
Q2
$1.55M Buy
+32,200
New +$1.4M ﹤0.01% 3042
2020
Q1
Sell
-242,365
Closed -$8.69M 6403
2019
Q4
$8.69M Buy
+242,365
New +$9.01M ﹤0.01% 1510
2018
Q4
Sell
-33,950
Closed -$1.36M 7260
2018
Q3
$1.36M Buy
+33,950
New +$1.36M ﹤0.01% 3316

Other funds holding QGEN

Barclays's QGEN Position: Q2 2026 in Review

Barclays increased its Qiagen (QGEN) stake by 6.5% in Q2 2026, buying an estimated $3.26M and bringing the position to 1,433,563 shares worth $56.1M. The position accounts for 0.01% of the portfolio, ranked #693.

Barclays first reported a position in QGEN in Q1 2017 and has held it in 38 quarters since. The position peaked at $130M in Q4 2021. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Barclays held 1,433,563 shares of Qiagen worth $56.1M as of Q2 2026.
  • Barclays bought 87,749 Qiagen shares in Q2 2026, an estimated $3.26M.
  • Qiagen made up 0.01% of Barclays's portfolio in Q2 2026, its #693 holding.
  • Barclays first reported a position in Qiagen in Q1 2017 and has held it in 38 quarters since.
  • Barclays's Qiagen position peaked at $130M in Q4 2021.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.